ReviewCurrent rheumatology reports2007
Axial disease in psoriatic arthritis.
Review in Current rheumatology reports, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
45 citing papers in PubMed, 1 synthesis or guideline pooled it, 131 citations in OpenAlex.
- Differences in clinical features between axial psoriatic arthritis and axial spondyloarthritis: a systematic review and meta-analysis of observational studies.Frontiers in medicine · 2026Pooled it
- Inflammatory back pain in psoriatic arthritis is significantly more responsive to corticosteroids compared to back pain in ankylosing spondylitis: a prospective, open-labelled, controlled pilot study.Arthritis research & therapy · 2018Trial
- Quantifying bone marrow inflammatory edema in the spine and sacroiliac joints with thresholding.BMC musculoskeletal disorders · 2017Trial
- IgA anti-CD74 autoantibodies are associated with treatment escalation in peripheral psoriatic arthritis.Frontiers in immunology · 2026Article
- Using ultrasound to define inflammatory and non-inflammatory phenotypes in difficult-to-treat psoriatic arthritis.RMD open · 2025Article
- Diagnostic delay in patients with psoriatic arthritis from dermatology and rheumatology clinics: a medical record review study.Clinical rheumatology · 2025Article
- Sami patients in northern Norway experience longer symptoms duration before psoriatic arthritis diagnosis and have more axial involvement.Rheumatology advances in practice · 2025Article
- Efficacy and retention rate of secukinumab in psoriatic arthritis across different clinical phenotypes: insights from the Italian GISEA Registry.Therapeutic advances in musculoskeletal disease · 2025Article
- Sacroiliac and spine imaging in spondyloarthritis: Does phenotype or sex matter?Advances in rheumatology (London, England) · 2024Article
- The ATTRACT study: screening for the early identification of axial psoriatic arthritis in a cohort of Italian psoriatic patients.Rheumatology (Oxford, England) · 2024Article
- Axial Disease in Psoriatic Arthritis: A Challenging Domain in Clinical Practice.Diagnostics (Basel, Switzerland) · 2024Review
- Psoriasis as a Systemic Disease.Deutsches Arzteblatt international · 2024Review
- Specific descriptions of axial involvement are associated with radiographic damage development after 2 years in psoriatic arthritis patients.Annals of the rheumatic diseases · 2024Article
- A Patient Survey Exploring the Burden of Inflammatory Back Pain in Patients With Known Psoriasis.Cureus · 2024Article
- Characteristics of patients with psoriatic arthritis in Korea: focusing on axial involvement.The Korean journal of internal medicine · 2024Article
- Efficacy of Guselkumab on Axial-Related Symptoms Through up to 2 Years in Adults with Active Psoriatic Arthritis in the Phase 3, Randomized, Placebo-Controlled DISCOVER-2 Study.Rheumatology and therapy · 2023Article
- Clinical significance of possible HLA biomarkers in axial spondyloarthritis beyond HLA-B27 positivity.Rheumatology international · 2023Article
- Article
- Article
- The effect of ixekizumab on axial manifestations in patients with psoriatic arthritis from two phase III clinical trials: SPIRIT-P1 and SPIRIT-P2.Therapeutic advances in musculoskeletal disease · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The definition of axial disease in psoriatic arthritis has varied from isolated unilateral grade 2 sacroiliitis to criteria similar to those used for ankylosing spondylitis. Depending on the definition used, the prevalence of axial disease varies from 25% to 70% of patients with psoriatic arthritis. This article reviews the prevalence, clinical and radiologic features, pathogenesis, prognosis, and treatment of psoriatic spondylitis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.